Aktionsplan Clinuvel Pharmaceuticals Limited
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen Clinuvel Pharmaceuticals Limited
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). weitere details| ISIN | US1887691038 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0.3469 |
| Дивиденд ао | 0.034 |
| Сайт | https://www.clinuvel.com |
| Цена ао | 7.63 |
| Preisänderung pro Tag: | 0% (6.9) |
|---|---|
| Preisänderung pro Woche: | +7.41% (6.424) |
| Preisänderung pro Monat: | -5.48% (7.3) |
| Preisänderung über 3 Monate: | -5.22% (7.28) |
| Preisänderung über sechs Monate: | -29.23% (9.75) |
| Preisänderung pro Jahr: | -29.23% (9.75) |
| Preisänderung über 3 Jahre: | -47.91% (13.2465) |
| Preisänderung über 5 Jahre: | -60.77% (17.59) |
| Preisänderung seit Jahresbeginn: | -7.88% (7.49) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institutionen | Volumen | Aktie, % |
|---|---|---|
| Trust For Professional Managers-PMC Diversified Equity Fund | 4782 | 0.01 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Dr. Philippe Jacques Wolgen M.B.A., M.D. | CEO, MD & Director | 1.86M | 1963 (62 Jahr) |
| Mr. Lachlan Hay | Chief Operations Officer | N/A | |
| Mr. Malcolm Bull | Head of Australian Operations & Investor Relations | N/A | |
| Dr. Rose Quadbeck-Diel | Senior Vice President of Regulatory Affairs | N/A | |
| Dr. Azza Hamila | Head of Quality Assurance & Drug Safety | N/A | |
| Dr. Dennis J. Wright BPharm, M.Sc., Ph.D. | Chief Scientific Officer | ||
| Mr. Peter Vaughan | Chief Financial Officer | ||
| Ms. Claire Newstead-Sinclair C.A. | Company Secretary |
Adresse: Australia, Melbourne. VIC, 535 Bourke Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.clinuvel.com
Webseite: https://www.clinuvel.com
